MNTA receives US patent on Lovenox characterization; Teva has no known expertise in Lovenox characterization; Teva may have disincentive to disclose Lovenox status; notes on 9/13/10 Morgan Stanley webcast; musings on Ram’s decision to leave BoD; revised table of insider shareholdings.
Stop telling people to post their messages. This is a public message board. Anyone can post their opions or any messages that they want. That why we have message board. Use the ignore button if you do not want to see it or do not prefer to see a post message from certain member.